Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
2
×
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
third rock ventures
ally bridge group
antisense oligonucleotide
benzodiazepines
big data analytics
biogen
blackrock
blackstone group
blackstone life sciences
casdin capital
columbia university
david goldstein
depression
diabetic nephropathy
epi4k
epilepsy
essential tremor
eventide asset management
focal segmental glomerulosclerosis
goldfinch bio
investing
irving investors
jay ghosh
kiran reddy
major depressive disorder
marcio souza
new york blog main
new york top stories
perimenopausal depression
praxis precision medicines
ptc therapeutics
schroeder adveq
What
genetic
2
×
medicines
new
2
×
aims
analysis
backed
bio
biotech
bring
cause
ceo
company
develop
diseases
drug
drugs
employing
epilepsy
genes
goldfinch
ipo
kidney
later
lead
links
marcio
million
mutations
neuro
praxis
precision
raised
raises
research
souza
stop
studies
turn
Language
unset
Current search:
boston
×
genetic
×
new
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
